TY - JOUR AU - AlRuthia, Yazed AU - Alharbi, Othman AU - Aljebreen, Abdulrahman M. AU - Azzam, Nahla A. AU - Almadi, Majid A. AU - Bahari, Ohud H. AU - Almalki, Khalid A. AU - Atham, Abdulaziz T. AU - Alanazi, Ahmed S. AU - Saeed, Maria AU - HajkhderMullaissa, Baraa AU - Alsenaidy, Mohammad AU - Balkhi, Bander PY - 2019 DA - 2019/12/04 TI - Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia JO - Cost Effectiveness and Resource Allocation SP - 25 VL - 17 IS - 1 AB - There has been an increase in incidence and prevalence of inflammatory bowel disease (IBD) outside the western countries. Treatment costs are an essential component for healthcare planning and priority setting. The utilization patterns and annual administration and cost of IBD medications are largely unknown in countries with an increasing incidence of disease, Saudi Arabia being an example. SN - 1478-7547 UR - https://doi.org/10.1186/s12962-019-0194-3 DO - 10.1186/s12962-019-0194-3 ID - AlRuthia2019 ER -